
ZH = {
    "title": "é¢„åç ”ç©¶æ ·æœ¬é‡è®¡ç®—å·¥å…· (Prognostic Research Sample Size Tool)",
    "sidebar_title": "é…ç½® (Configuration)",
    "language": "è¯­è¨€ / Language",
    "mode": "æ–¹æ³•é€‰æ‹© (Method Selection)",
    "mode_riley": "æ–¹æ³• C5: Riley ç­‰ (è§£ææ³•)",
    "mode_bayes": "æ–¹æ³• C6: è´å¶æ–¯ä¸»è¦ (æ¨¡æ‹Ÿ)",
    "mode_single": "å•ä¸€åœºæ™¯ (Single Scenario)",
    "mode_batch": "æ•æ„Ÿæ€§åˆ†æ (Sensitivity Analysis)",
    "method1_tab": "æ–¹æ³• C5 (Riley)",
    "method2_tab": "æ–¹æ³• C6 (Bayesian)",
    "nav_title": "å¯¼èˆª (Navigation)",
    "nav_readme": "è¯¦ç»†æ–‡æ¡£ (README)",
    "nav_intro": "ä»‹ç»ä¸å…¬å¼ (Introduction & Formulas)",
    "nav_calc": "æ ·æœ¬é‡è®¡ç®—å™¨ (Calculator)",
    "intro_heading": "æ¬¢è¿ (Welcome)",
    "intro_text": "æœ¬å·¥å…·å¸®åŠ©ç ”ç©¶äººå‘˜è®¡ç®—å¼€å‘äºŒåˆ†ç±»ç»“æœä¸´åºŠé¢„æµ‹æ¨¡å‹æ‰€éœ€çš„æœ€å°æ ·æœ¬é‡ã€‚",
    "formula_heading": "æ•°å­¦æ¡†æ¶ (æ–¹æ³• C5)",
    "formula_intro": "æ–¹æ³• C5 ä½¿ç”¨ Riley ç­‰äººæä¾›çš„è§£æè§£ï¼Œè€Œæ–¹æ³• C6 ä½¿ç”¨è´å¶æ–¯ MCMC æ¨¡æ‹Ÿã€‚",
    "sens_guide_title": "ğŸ’¡ å¦‚ä½•ä½¿ç”¨æ•æ„Ÿæ€§åˆ†æ (æ‰¹å¤„ç†æ¨¡å¼)",
    "sens_guide_text": """
    - **èŒƒå›´**: è¾“å…¥ `min-max` (ä¾‹å¦‚ `0.05-0.10`)ã€‚åº”ç”¨å°†è‡ªåŠ¨ç”Ÿæˆæ­¥éª¤ã€‚
    - **ç‰¹å®šå€¼**: è¾“å…¥é€—å·åˆ†éš”åˆ—è¡¨ (ä¾‹å¦‚ `0.05, 0.10, 0.15`)ã€‚
    """,
    "detail_view": "æŸ¥çœ‹åœºæ™¯è¯¦ç»†è®¡ç®—",
    "footer_refs": "å‚è€ƒæ–‡çŒ®: Riley et al. (2018, 2020), BayesAssurance.",
    "calc_btn": "è®¡ç®— (Calculate)",
    "results": "ç»“æœ (Results)",
    "sanity": "åˆç†æ€§æ£€æŸ¥ (Sanity Check - EPV Rules)",
    "download_csv": "ä¸‹è½½ CSV",
    "download_report": "ä¸‹è½½å®Œæ•´æŠ¥å‘Š",
    "error_p": "æ‚£ç—…ç‡å¿…é¡»åœ¨ 0 å’Œ 1 ä¹‹é—´ã€‚",
    "error_auc": "AUC å¿…é¡»åœ¨ 0.5 å’Œ 1 ä¹‹é—´ã€‚",
    "error_parse": "æ— æ³•è§£æè¾“å…¥ã€‚",
    
    # Riley specific
    "riley_inputs": "è¾“å…¥å‚æ•° (Riley)",
    "prevalence": "ç»“æœæ‚£ç—…ç‡ / äº‹ä»¶å‘ç”Ÿç‡ (Outcome Prevalence / Event Rate)",
    "prevalence_help": "å‚ä¸è€…å‘ç”Ÿäº‹ä»¶çš„æ¯”ä¾‹ (0 < p < 1)ã€‚",
    "parameters": "é¢„æµ‹å‚æ•°æ•°é‡ (Number of Predictor Parameters/df)",
    "parameters_help": "æ€»è‡ªç”±åº¦ (ä¸åŒ…æ‹¬æˆªè·)ã€‚",
    "shrinkage": "ç›®æ ‡å…¨å±€æ”¶ç¼©ç‡ (Target Global Shrinkage, S)",
    "shrinkage_help": "æœŸæœ›çš„æ”¶ç¼©å› å­ (é»˜è®¤ 0.9)ã€‚",
    "perf_measure": "é¢„æœŸæ€§èƒ½ (Anticipated Performance)",
    "perf_auc": "AUC (C-ç»Ÿè®¡é‡)",
    "perf_r2": "Cox-Snell R-squared",
    "perf_cons": "ä¿å®ˆä¼°è®¡ (æœ€å¤§ R2 çš„ 15%)",
    
    # Bayesian specific 
    "perf_cons_help": "ä¿å®ˆä¼°è®¡ (æœ€å¤§ R2 çš„ 15%)",
    "perf_auc_help": "é¢„æœŸ AUC (C-ç»Ÿè®¡é‡)",
    "perf_r2_help": "é¢„æœŸ Cox-Snell R-squared",
    
    # Bayesian specific
    "bayes_inputs": "æ¨¡æ‹Ÿè®¾ç½® (è´å¶æ–¯ä¿è¯)",
    "dgm_settings": "æ•°æ®ç”Ÿæˆæœºåˆ¶ (Data Generating Mechanism)",
    "sim_settings": "æ¨¡æ‹Ÿä¸ MCMC (Simulation & MCMC)",
    "eval_settings": "è¯„ä¼°æ ‡å‡† (Evaluation Criteria)",
    "n_candidates": "å€™é€‰æ ·æœ¬é‡ (é€—å·åˆ†éš”)",
    "n_candidates_help": "è¦æµ‹è¯•çš„ N å€¼åˆ—è¡¨ï¼Œä¾‹å¦‚ 500, 1000, 1500ã€‚",
    "correlation": "é¢„æµ‹å› å­ç›¸å…³æ€§ (rho)",
    "n_sims": "æ¯ä¸ª N çš„æ¨¡æ‹Ÿæ¬¡æ•°",
    "assurance_threshold": "ä¿è¯é˜ˆå€¼ (ç›®æ ‡æ¦‚ç‡, Assurance Threshold)",
    "run_simulation": "è¿è¡Œè´å¶æ–¯æ¨¡æ‹Ÿ",
    "simulation_running": "æ­£åœ¨è¿è¡Œæ¨¡æ‹Ÿ... è¿™å¯èƒ½éœ€è¦ä¸€äº›æ—¶é—´ã€‚",
    "assurance_result": "ä¿è¯åˆ†æ (Assurance Analysis)",
    
    # Method 6 (Dev Sim)
    "mode_dev_sim": "æ–¹æ³• 6: å¼€å‘æ¨¡æ‹Ÿ (é¢‘ç‡å­¦æ´¾)",
    "method6_tab": "æ–¹æ³• 6 (æ¨¡æ‹Ÿ)",
    "dev_sim_intro": "åŸºäºæ¨¡æ‹Ÿçš„æ¨¡å‹å¼€å‘æ ·æœ¬é‡è®¡ç®— (é¢‘ç‡å­¦æ´¾æ–¹æ³•ï¼Œç±»ä¼¼äº `samplesizedev`)ã€‚",
    "dev_mode_simple": "æ¨¡å¼ A: ç®€å• (AUC é©±åŠ¨)",
    "dev_mode_custom": "æ¨¡å¼ B: è‡ªå®šä¹‰ DGM",
    "target_auc": "ç›®æ ‡å¹³å‡ AUC (C-ç»Ÿè®¡é‡)",
    "target_auc_help": "ç®—æ³•å°†å¯»æ‰¾ Beta ç³»æ•°ä»¥å®ç°æ­¤ AUCã€‚",
    "criteria_settings": "æ€§èƒ½æ ‡å‡† (é€šè¿‡/å¤±è´¥)",
    "crit_slope_mean": "å¹³å‡æ ¡å‡†æ–œç‡ (Calibration Slope) >= 0.9",
    "crit_slope_ci": "Pr(0.9 <= Slope <= 1.1) >= 80%",
    "crit_auc": "å¹³å‡ AUC >= ç›®æ ‡å€¼",
    "audit_trail": "RNG å®¡è®¡è·Ÿè¸ª (JSON)",
    "future_methods": "å³å°†æ¨å‡ºçš„ç‰ˆæœ¬...",
    
    # Quick Methods
    "method_quick_tab": "A. å¿«é€Ÿ / åŸºç¡€ (Quick / Basic)",
    "quick_mode_epv": "A1: EPV / EPP è§„åˆ™ (å¯å‘å¼)",
    "quick_mode_risk": "A2: åŸºçº¿é£é™©ç²¾åº¦ (CI å®½åº¦)",
    "target_epv": "ç›®æ ‡æ¯å‚æ•°äº‹ä»¶æ•° (EPP)",
    "target_epv_help": "å¸¸è§çš„å¯å‘å¼å€¼ä¸º 10, 15, 20ã€‚EPP ä¼˜äº EPVã€‚",
    "epv_warning_title": "âš ï¸ é‡è¦è­¦å‘Š",
    "epv_warning_text": "EPV/EPP åªæ˜¯ç²—ç•¥çš„å¯å‘å¼è§„åˆ™ã€‚å®ƒä¸èƒ½ä¿è¯æ ¡å‡†ã€åŒºåˆ†åº¦ï¼Œä¹Ÿä¸èƒ½é˜²æ­¢ä¹è§‚åå·®ã€‚å®ƒå¯¹å˜é‡é€‰æ‹©å’Œéçº¿æ€§é¡¹æ•æ„Ÿã€‚",
    "ci_level": "ç½®ä¿¡æ°´å¹³ (Confidence Level)",
    "ci_half_width": "ç›®æ ‡åŠå®½ (è¯¯å·®è¾¹é™…, Margin of Error)",
    "ci_method": "CI æ–¹æ³•",
    "ci_method_wilson": "Wilson Score (æ¨è)",
    "ci_method_wald": "Wald (ç®€å•)",
    "ci_method_cp": "Clopper-Pearson (ä¿å®ˆ)",
    "risk_help": "è®¡ç®—ä¼°è®¡ç‰¹å®šç²¾åº¦çš„äº‹ä»¶å‘ç”Ÿç‡ p æ‰€éœ€çš„ Nã€‚ä¸ä¿è¯é¢„æµ‹æ¨¡å‹æ€§èƒ½ã€‚",
    
    # Power Methods (B)
    "title_b3": "B3: Logistic åŠŸæ•ˆ (Hsieh)",
    "title_b4": "B4: Cox åŠŸæ•ˆ (Schoenfeld)",
    "interpretation": "è§£é‡Š (Interpretation)",
    
    # UI Basics
    "d8_assumptions": "**å‡è®¾**: ä½¿ç”¨ Hanley & McNeil (1982) æ–¹å·®è¿‘ä¼¼ã€‚AUC å¯¹ç§°æ­£æ€å‡è®¾ã€‚æ•°å€¼ä¼˜åŒ–å¯»æ‰¾ Nã€‚",
    "d8_mode_n_to_width": "ä» N è®¡ç®— CI å®½åº¦",
    "d8_mode_width_to_n": "ä» CI å®½åº¦è®¡ç®—æ‰€éœ€ N",
    "d8_opt_settings": "é«˜çº§ä¼˜åŒ–å™¨è®¾ç½®",
    "d8_practical_rounding": "æ˜¾ç¤ºå®é™…å–æ•´",
    "d8_n_input": "æ ·æœ¬é‡ (N)",
    "d8_width_input": "CI å®½åº¦ (æ€»)",
    "d8_opt_bound": "æœç´¢ä¸Šé™",
    "d8_opt_tol": "å®¹å·®",
    
    # Validations (D)
    "title_d8": "D8: AUC ç²¾åº¦ (Hanley-McNeil)",
    "d8_desc": "è®¡ç®—ä»¥æ‰€éœ€ç²¾åº¦ (CI å®½åº¦) ä¼°è®¡ AUC çš„æ ·æœ¬é‡ã€‚",
    "auc_expected": "é¢„æœŸ AUC (C-ç»Ÿè®¡é‡)",
    "formulas_header": "ğŸ“š å…¬å¼ä¸æŠ€æœ¯ç»†èŠ‚ (Formulas & Technical Details)",
    "d8_assumptions": "**å‡è®¾**: ä½¿ç”¨ Hanley & McNeil (1982) æ–¹å·®è¿‘ä¼¼ã€‚AUC å¯¹ç§°æ­£æ€å‡è®¾ã€‚æ•°å€¼ä¼˜åŒ–å¯»æ‰¾ Nã€‚",
    "d8_mode_n_to_width": "ä» N è®¡ç®— CI å®½åº¦",
    "d8_mode_width_to_n": "ä» CI å®½åº¦è®¡ç®— N",
    "d8_opt_settings": "é«˜çº§ä¼˜åŒ–å™¨è®¾ç½®",
    "d8_practical_rounding": "æ˜¾ç¤ºå®é™…å–æ•´",
    "d8_n_input": "æ ·æœ¬é‡ (N)",
    "d8_width_input": "CI å®½åº¦ (æ€»)",
    "d8_opt_bound": "æœç´¢ä¸Šé™",
    "d8_opt_tol": "å®¹å·®",
    
    # D9
    "title_d9": "D9: å¤–éƒ¨éªŒè¯ (Tailored)",
    "common_inputs": "é€šç”¨å‚æ•°",
    
    # UI Basics
    "search_placeholder": "æœç´¢æ–¹æ³•...",
    "settings": "è®¾ç½® (Settings)",
    
    # Footer
    "footer_copyright": "Â© 2026 é¢„åç ”ç©¶æ ·æœ¬é‡è®¡ç®—å·¥å…·ã€‚ä»…ä¾›å­¦æœ¯/ç ”ç©¶ä½¿ç”¨ã€‚",
    "footer_author": "ä½œè€…ä¸ç»´æŠ¤: Minh Nguyen (minhnt@ump.edu.vn) - Dept. of Epidemiology, Faculty of Public Health, UMP Ho Chi Minh City",
    "footer_disclaimer": "å…è´£å£°æ˜: æ— ä¸´åºŠä¿è¯ï¼›ç”¨æˆ·è´Ÿè´£éªŒè¯å’Œè§£é‡Šã€‚",

    "intro_complete_md": """
### æ¬¢è¿ (Welcome)

æœ¬åº”ç”¨å¸®åŠ©ä¸´åºŠåŒ»ç”Ÿå’Œç ”ç©¶äººå‘˜è§„åˆ’é¢„åç ”ç©¶çš„æœ€å°æ ·æœ¬é‡ï¼ŒåŒ…æ‹¬ï¼š
* é¢„åå› ç´ ç ”ç©¶ (æ£€æµ‹å…³è”çš„åŠŸæ•ˆ)ï¼Œ
* ä¸´åºŠé¢„æµ‹æ¨¡å‹å¼€å‘ (é£é™©é¢„æµ‹)ï¼Œä»¥åŠ
* æ¨¡å‹éªŒè¯ / æ›´æ–° (å¤–éƒ¨éªŒè¯ï¼Œé‡æ–°æ ¡å‡†)ã€‚

å®ƒä¸“ä¸ºäºŒåˆ†ç±»ç»“æœ (ä¾‹å¦‚ï¼šäº‹ä»¶ vs æ— äº‹ä»¶) è®¾è®¡ï¼Œéƒ¨åˆ†æ¨¡å—ä¹Ÿé€‚ç”¨äºç”Ÿå­˜æ—¶é—´ç»“æœ (Cox PH)ã€‚

æºä»£ç  (ä¸‹è½½): [https://gitlab.com/minhthiennguyen/pmsample/](https://gitlab.com/minhthiennguyen/pmsample/)
æˆ– [https://github.com/nguyenminh2301/pmsample.git](https://github.com/nguyenminh2301/pmsample.git)    

###ä»¥æ­¤å¼€å§‹ (æ–°ç”¨æˆ·)

#### 1. æ˜ç¡®æ‚¨çš„ç ”ç©¶ç›®æ ‡
* æ‚¨æ˜¯åœ¨æµ‹è¯•å•ä¸ªé¢„åå› ç´  (å…³è”æ€§) å—ï¼Ÿ
* æ‚¨æ˜¯åœ¨æ„å»ºé¢„æµ‹æ¨¡å‹å—ï¼Ÿ
* æ‚¨æ˜¯åœ¨æ–°äººç¾¤ä¸­éªŒè¯ç°æœ‰æ¨¡å‹å—ï¼Ÿ

#### 2. ä¼°è®¡äº‹ä»¶å‘ç”Ÿç‡ $p$ (æˆ–ç”Ÿå­˜åˆ†æçš„äº‹ä»¶åˆ†æ•°)
* é¦–é€‰å½“åœ°åŒ»é™¢æ•°æ® (æœ€ä½³)ã€‚
* å¦‚æœä¸ç¡®å®šï¼Œè¯·è¾“å…¥ä¸€ä¸ªèŒƒå›´å¹¶è¿è¡Œæ•æ„Ÿæ€§åˆ†æã€‚

#### 3. æ­£ç¡®è®¡ç®—æ¨¡å‹å¤æ‚æ€§ (å‚æ•° / è‡ªç”±åº¦)
ä½¿ç”¨å‚æ•° (è‡ªç”±åº¦)ï¼Œè€Œä¸ä»…ä»…æ˜¯â€œå˜é‡æ•°é‡â€ã€‚
* äºŒåˆ†ç±»é¢„æµ‹å˜é‡: 1 df
* å…·æœ‰ $L$ ä¸ªæ°´å¹³çš„åˆ†ç±»å˜é‡: $L-1$ df
* æ ·æ¡ (å…·æœ‰ $K$ ä¸ªèŠ‚ç‚¹çš„ RCS): $K-1$ df
* äº¤äº’ä½œç”¨: $df(A \\times B) = df(A) \\cdot df(B)$

#### 4. ä»ä¸‹é¢çš„ç›®å½•ä¸­é€‰æ‹©ä¸€ç§æ–¹æ³•
* **"å¿«é€Ÿå·¥å…·" (Quick tools)** ä»…ç”¨äºç²—ç•¥è§„åˆ’ã€‚
* å¼€å‘é¢„æµ‹æ¨¡å‹æ—¶ä½¿ç”¨ **Riley / æ¨¡æ‹Ÿ / ä¿è¯ (Assurance)** æ–¹æ³•ã€‚

---

### ä½•æ—¶ä½¿ç”¨æ­¤åº”ç”¨ (ä»¥åŠä½•æ—¶ä¸ä½¿ç”¨)

**åœ¨ä»¥ä¸‹æƒ…å†µä¸‹ä½¿ç”¨æ­¤åº”ç”¨:**
* è§„åˆ’é¢„å/é¢„æµ‹æ–¹é¢çš„å›é¡¾æ€§æˆ–å‰ç»æ€§é˜Ÿåˆ—ç ”ç©¶
* å¼€å‘æˆ–éªŒè¯é£é™©é¢„æµ‹æ¨¡å‹
* æ ¹æ®æµè¡Œç‡æˆ– AUC çš„ç²¾åº¦ (CI å®½åº¦) ä¼°è®¡æ ·æœ¬é‡
* è®¾è®¡å…·æœ‰æ ¡å‡†å’ŒåŒºåˆ†åº¦ç›®æ ‡çš„å¤–éƒ¨éªŒè¯

**åœ¨ä»¥ä¸‹æƒ…å†µä¸‹ä¸è¦å°†æ­¤åº”ç”¨ä½œä¸ºä¸»è¦å·¥å…·:**
* è®¾è®¡éšæœºå¯¹ç…§è¯•éªŒ (ä½¿ç”¨ RCT ç‰¹å®šçš„åŠŸæ•ˆ/æ ·æœ¬é‡æ–¹æ³•)
* åœ¨æ²¡æœ‰é¢„æµ‹å»ºæ¨¡çš„æƒ…å†µä¸‹è§„åˆ’æ•æ„Ÿæ€§/ç‰¹å¼‚æ€§çš„è¯Šæ–­å‡†ç¡®æ€§ç ”ç©¶
* æœŸæœ›ä¸€ä¸ªå•ä¸€çš„â€œæ­£ç¡®â€æ•°å­—ï¼šæ ·æœ¬é‡è§„åˆ’éœ€è¦å‡è®¾ï¼Œå¹¶ä¸”åº”åŒ…æ‹¬æ•æ„Ÿæ€§åˆ†æ

---

### å¯ç”¨æ–¹æ³• (æ¦‚è§ˆ)

#### A. å¿«é€Ÿ / åŸºç¡€ (å¿«é€Ÿï¼Œè¿‘ä¼¼)

**A1 â€” ç»éªŒæ³•åˆ™ (EPV/EPP) (å¯å‘å¼)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨éœ€è¦å¿«é€Ÿæ£€æŸ¥äº‹ä»¶å¯¹äºè®¡åˆ’çš„æ¨¡å‹è§„æ¨¡æ˜¯å¦â€œå¤§è‡´è¶³å¤Ÿâ€ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ¨¡å‹åŒ…å«æ ·æ¡/äº¤äº’ä½œç”¨/å˜é‡é€‰æ‹©ï¼Œæˆ–äº‹ä»¶å‘ç”Ÿç‡ä½â€”â€”EPV/EPP ä¸èƒ½ä¿è¯è‰¯å¥½çš„æ ¡å‡†æˆ–ä½ä¹è§‚åå·®ã€‚
* **ä¸»è¦è¾“å…¥:** äº‹ä»¶å‘ç”Ÿç‡ $p$, å‚æ•°æ•°é‡ $P$ (df), ç›®æ ‡ EPP (ä¾‹å¦‚ 10/15/20)
* **æ ¸å¿ƒè¾“å‡º:** æ‰€éœ€äº‹ä»¶ $E=t \\cdot P$, æ‰€éœ€æ ·æœ¬é‡ $N=\\lceil E/p \\rceil$
* **ä¼˜ç‚¹:** æå…¶ç®€å•ï¼›é€‚åˆæ—©æœŸå¯è¡Œæ€§ç ”ç©¶
* **ç¼ºç‚¹:** å¯èƒ½å…·æœ‰è¯¯å¯¼æ€§ï¼›éåŸºäºæ€§èƒ½

**A2 â€” åŸºçº¿é£é™©ç²¾åº¦ (æ‚£ç—…ç‡çš„ CI å®½åº¦)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨çš„ç›®æ ‡æ˜¯ä»¥æ‰€éœ€çš„ CI åŠå®½ (ä¾‹å¦‚ Â±2%) ä¼°è®¡äº‹ä»¶å‘ç”Ÿç‡ $p$ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨æƒ³è¦é¢„æµ‹æ¨¡å‹æ€§èƒ½ä¿è¯ (AUC/æ ¡å‡†æ–œç‡)ã€‚
* **ä¸»è¦è¾“å…¥:** é¢„æœŸ $p$, CI æ–¹æ³• (æ¨è Wilson), ç½®ä¿¡æ°´å¹³, ç›®æ ‡åŠå®½ $d$
* **æ ¸å¿ƒè¾“å‡º:** æ»¡è¶³ CI åŠå®½ $\\le d$ çš„æœ€å° $N$
* **ä¼˜ç‚¹:** ç›´æ¥çš„ç²¾åº¦ç›®æ ‡ï¼›å‡è®¾é€æ˜
* **ç¼ºç‚¹:** ä»…å…³äºæ‚£ç—…ç‡ï¼Œè€Œéæ¨¡å‹æ€§èƒ½

#### B. é¢„åå› ç´  (åŠŸæ•ˆ) (å…³æ³¨å…³è”æ€§ï¼Œè€Œéé¢„æµ‹æ¨¡å‹å¤§å°)

**B3 â€” Logistic OR åŠŸæ•ˆ (Hsieh)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨å¸Œæœ›åœ¨ Logistic å›å½’ä¸­æ£€æµ‹é¢„åå› ç´ çš„ç›®æ ‡æ¯”å€¼æ¯” (OR) çš„åŠŸæ•ˆã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨çš„ä¸»è¦ç›®æ ‡æ˜¯é¢„æµ‹æ¨¡å‹å¼€å‘ (æ ¡å‡†/åŒºåˆ†åº¦)ï¼Œè€Œä¸æ˜¯å‡è®¾æ£€éªŒã€‚
* **ä¸»è¦è¾“å…¥:** åŸºçº¿é£é™© $p_0$, ç›®æ ‡ OR, Alpha, åŠŸæ•ˆ, æš´éœ²æ‚£ç—…ç‡ (äºŒåˆ†ç±») æˆ– SD (è¿ç»­), å¯é€‰çš„ä¸å…¶ä»–åå˜é‡çš„ $R^2$
* **æ ¸å¿ƒè¾“å‡º:** æ£€æµ‹ OR æ‰€éœ€çš„ $N$ (åŠéšå«äº‹ä»¶æ•°)
* **ä¼˜ç‚¹:** ç”¨äºå…³è”æ€§çš„ç»å…¸åŠŸæ•ˆæ¡†æ¶
* **ç¼ºç‚¹:** ä¸è§£å†³é¢„æµ‹æ¨¡å‹æ€§èƒ½é—®é¢˜ï¼›å¯¹è¾“å…¥å‡è®¾æ•æ„Ÿ

**B4 â€” Cox HR åŠŸæ•ˆ (Schoenfeld)**
* **é€‚ç”¨æƒ…å†µ:** ç”Ÿå­˜æ—¶é—´ç»“æœï¼›æ‚¨å¸Œæœ›åœ¨ Cox PH ä¸‹æ£€æµ‹é£é™©æ¯” (HR) çš„åŠŸæ•ˆã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** PH å‡è®¾å¯èƒ½è¢«è¿åï¼Œæˆ–äº‹ä»¶åˆ†æ•°é«˜åº¦ä¸ç¡®å®šä¸”æ— æ³•åˆç†ä¼°è®¡ã€‚
* **ä¸»è¦è¾“å…¥:** HR, Alpha, åŠŸæ•ˆ, åˆ†é…æ¯”ä¾‹ (äºŒåˆ†ç±») æˆ– SD (è¿ç»­), éšè®¿æœŸé—´çš„é¢„æœŸäº‹ä»¶åˆ†æ•°
* **æ ¸å¿ƒè¾“å‡º:** æ‰€éœ€äº‹ä»¶æ•°ï¼›ä½¿ç”¨äº‹ä»¶åˆ†æ•°è½¬æ¢ä¸º $N$
* **ä¼˜ç‚¹:** å¹¿æ³›æ¥å—ï¼›åŸºäºäº‹ä»¶çš„è§„åˆ’ç›´è§‚
* **ç¼ºç‚¹:** å¼ºçƒˆä¾èµ–äºäº‹ä»¶åˆ†æ•°å’Œéšè®¿/åˆ å¤±å‡è®¾

#### C. é¢„æµ‹æ¨¡å‹å¼€å‘ (æ¨èç”¨äºé£é™©æ¨¡å‹æ„å»º)

**C5 â€” Riley ç­‰ (è§£ææ³•; ç±»ä¼¼ pmsampsize)**
* **é€‚ç”¨æƒ…å†µ:** å¼€å‘å¤šå˜é‡é¢„æµ‹æ¨¡å‹ï¼›æ‚¨å¸Œæœ›æ§åˆ¶è¿‡æ‹Ÿåˆå‡ç¡®ä¿è¶³å¤Ÿçš„ç²¾åº¦ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨æ— æ³•æä¾›æ‚£ç—…ç‡å’Œé¢„æœŸæ¨¡å‹æ€§èƒ½ (AUC æˆ– $R^2$) çš„åˆç†å‡è®¾ï¼›åœ¨è¿™ç§æƒ…å†µä¸‹ï¼Œä½¿ç”¨æ•æ„Ÿæ€§åˆ†ææˆ–æ¨¡æ‹Ÿã€‚
* **ä¸»è¦è¾“å…¥:** äº‹ä»¶å‘ç”Ÿç‡ $p$, å‚æ•° $P$ (df), ç›®æ ‡æ”¶ç¼©ç‡ (ä¾‹å¦‚ 0.90), é¢„æœŸæ¨¡å‹æ€§èƒ½ (AUC æˆ– Coxâ€“Snell $R^2$)
* **æ ¸å¿ƒè¾“å‡º:** æ»¡è¶³å¤šä¸ªæ ‡å‡†çš„æœ€å° $N$ (è¿‡æ‹Ÿåˆæ§åˆ¶ + ç²¾åº¦)
* **ä¼˜ç‚¹:** åŸºäºåŸåˆ™ï¼Œå…³æ³¨æ€§èƒ½ï¼Œè¢«å¹¿æ³›å¼•ç”¨
* **ç¼ºç‚¹:** ä¾èµ–äºæ€§èƒ½å‡è®¾ï¼›éœ€è¦ä»”ç»†è®¡ç®— df

**C6 â€” å¼€å‘æ¨¡æ‹Ÿ (é¢‘ç‡å­¦æ´¾; samplesizedev/è‡ªå®šä¹‰ DGM)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨æ›´å–œæ¬¢â€œæ¨¡æ‹Ÿæ‚¨å°†è¦åšçš„äº‹æƒ…â€ï¼Œç‰¹åˆ«æ˜¯å­˜åœ¨éçº¿æ€§/äº¤äº’ä½œç”¨å’Œè‡ªå®šä¹‰æ•°æ®ç»“æ„æ—¶ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨æ— æ³•æŒ‡å®šåˆç†çš„æ•°æ®ç”Ÿæˆæœºåˆ¶ (DGM) æˆ–æ‚¨éœ€è¦å³æ—¶ç»“æœ (è®¡ç®—å¯†é›†å‹)ã€‚
* **ä¸»è¦è¾“å…¥:** å€™é€‰ $N$ ç½‘æ ¼, DGM å‡è®¾ (é¢„æµ‹å˜é‡åˆ†å¸ƒ/ç›¸å…³æ€§/æ•ˆåº”), æ€§èƒ½ç›®æ ‡ (ä¾‹å¦‚ æ ¡å‡†æ–œç‡èŒƒå›´, AUC é˜ˆå€¼), æ¨¡æ‹Ÿé‡å¤æ¬¡æ•°, ç§å­
* **æ ¸å¿ƒè¾“å‡º:** ä»¥å¯æ¥å—çš„æ¦‚ç‡/ç²¾åº¦è¾¾åˆ°ç›®æ ‡çš„æœ€å° $N$
* **ä¼˜ç‚¹:** çµæ´»ï¼›ä¸å¤æ‚å»ºæ¨¡ä¸€è‡´
* **ç¼ºç‚¹:** å‡è®¾ç¹é‡ï¼›è®¡ç®—æˆæœ¬é«˜

**C7 â€” è´å¶æ–¯ä¿è¯ (MCMC)**
* **é€‚ç”¨æƒ…å†µ:** æœ€ç»ˆæ¨¡å‹å°†ä½¿ç”¨è´å¶æ–¯ MCMC ä¼°è®¡ï¼Œå¹¶ä¸”æ‚¨å¸Œæœ›åŸºäºä¿è¯ (æ»¡è¶³åéªŒæ€§èƒ½/ç²¾åº¦ç›®æ ‡çš„æ¦‚ç‡) çš„æ ·æœ¬é‡ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** å…ˆéªŒæ— æ³•è¯æ˜æˆ–è®¡ç®—é¢„ç®—æœ‰é™ã€‚
* **ä¸»è¦è¾“å…¥:** DGM, å…ˆéªŒ, å€™é€‰ $N$, MCMC è®¾ç½®, ä¿è¯é˜ˆå€¼ (ä¾‹å¦‚ 80%/90%), æ€§èƒ½/ç²¾åº¦ç›®æ ‡
* **æ ¸å¿ƒè¾“å‡º:** æ»¡è¶³ä¿è¯é˜ˆå€¼çš„æœ€å° $N$
* **ä¼˜ç‚¹:** ä¸è´å¶æ–¯å·¥ä½œæµç¨‹ä¸€è‡´ï¼›ç›´æ¥é’ˆå¯¹åéªŒæ ‡å‡†
* **ç¼ºç‚¹:** è®¡ç®—å¯†é›†å‹ï¼›éœ€è¦å…ˆéªŒè§„èŒƒ

#### D. éªŒè¯ / æ›´æ–° (ç”¨äºç°æœ‰æ¨¡å‹)

**D8 â€” AUC ç²¾åº¦ (Hanleyâ€“McNeil / presize)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨çš„éªŒè¯ç›®æ ‡æ˜¯ AUC çš„ç²¾åº¦ (CI å®½åº¦)ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ ¡å‡† (æ–œç‡/CITL) æ˜¯ä¸»è¦å…³æ³¨ç‚¹â€”â€”æ­¤æ–¹æ³•ä»…é’ˆå¯¹ AUCã€‚
* **ä¸»è¦è¾“å…¥:** é¢„æœŸ AUC, æ‚£ç—…ç‡æˆ–ç—…ä¾‹å¯¹ç…§æ¯”, ç½®ä¿¡æ°´å¹³, ç›®æ ‡ CI å®½åº¦
* **æ ¸å¿ƒè¾“å‡º:** è¾¾åˆ°æ‰€éœ€ AUC CI å®½åº¦çš„æœ€å° $N$
* **ä¼˜ç‚¹:** ç®€å•ï¼›ç”¨äºåŒºåˆ†åº¦ç²¾åº¦çš„å¿«é€Ÿè§„åˆ’
* **ç¼ºç‚¹:** è¿‘ä¼¼æ–¹å·®ï¼›å¿½ç•¥æ ¡å‡†

**D9 â€” å¤–éƒ¨éªŒè¯ (Tailored; pmvalsampsize / sampsizeval)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨å¸Œæœ›é’ˆå¯¹å¤šä¸ªæ€§èƒ½æŒ‡æ ‡ (æ ¡å‡† + åŒºåˆ†åº¦) è¿›è¡ŒéªŒè¯è§„æ¨¡ç¡®å®šï¼Œé€šå¸¸éœ€è¦å…³äº LP åˆ†å¸ƒçš„å‡è®¾ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨æ— æ³•è¯æ˜ LP åˆ†å¸ƒå‡è®¾æˆ–é¢„æœŸæ€§èƒ½ã€‚
* **ä¸»è¦è¾“å…¥:** æ‚£ç—…ç‡, é¢„æœŸ AUC, æ ¡å‡†æ–œç‡/CITL ç›®æ ‡, CI å®½åº¦æˆ– SE ç›®æ ‡, LP åˆ†å¸ƒå‡è®¾
* **æ ¸å¿ƒè¾“å‡º:** æ»¡è¶³å„æŒ‡æ ‡ç²¾åº¦æ ‡å‡†çš„æ¨è $N$
* **ä¼˜ç‚¹:**ä»¥æ­¤å®šåˆ¶ï¼›å…³æ³¨æ ¡å‡†
* **ç¼ºç‚¹:** éœ€è¦é¢å¤–å‡è®¾ï¼›æ›´å¤æ‚

**D10 â€” å¤–éƒ¨éªŒè¯ (æ¨¡æ‹Ÿ; åŸºäº LP)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨å¯ä»¥æŒ‡å®š/ä¼°è®¡ç›®æ ‡éªŒè¯äººç¾¤ä¸­çº¿æ€§é¢„æµ‹å™¨ (LP) çš„åˆ†å¸ƒï¼Œå¹¶å¸Œæœ›è¿›è¡ŒåŸºäºæ¨¡æ‹Ÿçš„ç²¾åº¦è§„åˆ’ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** LP åˆ†å¸ƒæœªçŸ¥ä¸”æ— æ³•è¿‘ä¼¼ã€‚
* **ä¸»è¦è¾“å…¥:** LP åˆ†å¸ƒ (æ­£æ€/Beta/ç»éªŒ), è¯¯æ ¡å‡†å‚æ•°, æŒ‡æ ‡çš„ CI å®½åº¦ç›®æ ‡, é‡å¤æ¬¡æ•°, ç§å­
* **æ ¸å¿ƒè¾“å‡º:** æ¨¡æ‹Ÿä¸‹è¾¾åˆ°ç²¾åº¦ç›®æ ‡çš„æœ€å° $N$
* **ä¼˜ç‚¹:** éå¸¸çµæ´»ï¼›åŒ¹é…â€œæ¨¡æ‹Ÿæ‚¨çš„é¢„æœŸâ€
* **ç¼ºç‚¹:** å‡è®¾ç¹é‡ï¼›è®¡ç®—æˆæœ¬é«˜

**D11 â€” æ›´æ–° / é‡æ–°æ ¡å‡† (æˆªè·/æ–œç‡)**
* **é€‚ç”¨æƒ…å†µ:** æ‚¨å°†é‡æ–°æ ¡å‡†ç°æœ‰æ¨¡å‹ (æ›´æ–°æˆªè·å’Œ/æˆ–æ–œç‡) å¹¶éœ€è¦è¶³å¤Ÿçš„ç²¾åº¦ã€‚
* **ä¸é€‚ç”¨æƒ…å†µ:** æ‚¨æ­£åœ¨å¼€å‘å…¨æ–°çš„æ¨¡å‹ (ä½¿ç”¨ C5â€“C7)ã€‚
* **ä¸»è¦è¾“å…¥:** æ›´æ–°ç±»å‹ (ä»…æˆªè· vs æˆªè·+æ–œç‡), äº‹ä»¶å‘ç”Ÿç‡, ç²¾åº¦ç›®æ ‡
* **æ ¸å¿ƒè¾“å‡º:** è¶³ä»¥è¿›è¡Œç¨³å®šæ›´æ–°çš„ $N$
* **ä¼˜ç‚¹:** å®é™…éƒ¨ç½²å®ç”¨
* **ç¼ºç‚¹:** ä¾èµ–äºå½“åœ°ç—…ä¾‹ç»„åˆå’Œæ¨¡å‹å¯ç§»æ¤æ€§å‡è®¾

---

#### å…è´£å£°æ˜

æ— ä¸´åºŠä¿è¯ï¼›ç”¨æˆ·è´Ÿè´£éªŒè¯å’Œè§£é‡Šã€‚å§‹ç»ˆè®°å½•å‡è®¾å¹¶è¿è¡Œæ•æ„Ÿæ€§åˆ†æã€‚

#### è”ç³»æ–¹å¼

ä½œè€…ä¸ç»´æŠ¤: Minh Nguyen (minhnt@ump.edu.vn)
""",

    "a2_content_md": """
### What this is (English - Technical Details)

This module estimates the **minimum sample size (n)** needed to estimate the **baseline risk / event rate** (p) (i.e., prevalence of the outcome) with a **desired precision**, expressed as a **confidence interval (CI) half-width** (margin of error).

It is useful for:
* describing the outcome prevalence in a cohort with a specified precision,
* planning feasibility and reporting baseline risk,
* supporting calibration-related planning (e.g., calibration-in-the-large relies on the event rate).

**Important limitation:** This calculation **does not** ensure prediction model performance (AUC, calibration slope, optimism). It only targets precision for estimating (p).

---

### Inputs (what they mean)

1. **Outcome prevalence / event rate** (p)
   Expected proportion of events in the target population (e.g., 0.10).
   * If unknown, consider a plausible range and run a sensitivity analysis.
   * If you want a conservative â€œworst-caseâ€ for prevalence precision, use (p=0.50) (maximizes variance).

2. **Target half-width (margin of error)** (d)
   Desired precision such that the CI is approximately:
   $p \pm d$
   Examples: (d = 0.01, 0.02, 0.03) (i.e., Â±1%, Â±2%, Â±3%).

3. **Confidence level** (1-$\\alpha$)
   Typical values: 0.95 or 0.99.

4. **CI Method**
* **Wilson score (recommended):** better coverage than Wald, especially when (p) is near 0 or 1 or sample size is modest.
* **Wald (normal approximation):** simple closed form but can perform poorly for small (n) or extreme (p).
* **Clopperâ€“Pearson (exact):** conservative (often yields wider CIs; thus larger (n)).

---

### Core calculation

Let $X \sim \\text{Binomial}(n,p)$, $\hat p = X/n$. The goal is to find the smallest (n) such that the chosen CI method yields:
$$
\\frac{\\text{Upper}(n) - \\text{Lower}(n)}{2} \le d
$$

#### A) Wald (closed-form approximation)
$$ n \\approx \\frac{z^2 p(1-p)}{d^2} $$
**Note:** Fast but not recommended for small n or extreme p.

#### B) Wilson score interval (recommended)
Uses the Wilson score interval formula to find n. Since the interval depends on the observed count x, we iterate to find the smallest n where the half-width constraint is met for expected outcomes.

#### C) Clopperâ€“Pearson â€œexactâ€ interval
Uses Beta quantiles to form conservative intervals. Typically yields larger sample sizes.

---

### Practical defaults

* **Confidence level:** 95% is standard.
* **Half-width (d):** Â±0.01 to Â±0.03 (1%â€“3%) are common targets.
* **Method:** Wilson is a strong default.

### Key references
1. **Wilson EB.** Probable inference, the law of succession, and statistical inference. *JASA.* 1927.
2. **Newcombe RG.** Two-sided confidence intervals for the single proportion. *Stat Med.* 1998.
""",

    "b3_content_md": """
### Purpose (English - Technical Details)

This module estimates the **minimum sample size** needed to detect an association between a predictor (X) and a **binary outcome** (Y) using **logistic regression**, targeting a specified **odds ratio (OR)**, **two-sided ($\\alpha$)**, and **power**.

This is a **prognostic factor / association-focused** power calculation (testing a regression coefficient), **not** a prediction-model performance method. It does **not** guarantee good calibration or discrimination of a multivariable prediction model.

---

### When to use

Use B3 when:

* You want power to detect a **clinically meaningful OR** for a **single predictor** (binary or continuous) in logistic regression.
* Your primary goal is **hypothesis testing** (is the predictor associated with the outcome?), not building a risk prediction model.

### When NOT to use

Do not use B3 as your main approach when:

* Your goal is **prediction model development** (use Riley/pmsampsize or simulation/assurance methods).
* You plan **data-driven variable selection**, many interactions/splines, or complex machine-learning tuning (power for a single coefficient is not the right target).
* Data are **clustered** (multicenter/ward-level correlation) or strongly dependent without adjusting the design effect.
* You have a **caseâ€“control** design with fixed case/control sampling (baseline risks ($p_0$) may not represent the source population).

---

### Statistical model and parameters

Logistic regression model:
$$
\\text{logit}{P(Y=1\\mid X)}=\\beta_0+\\beta_1 X
$$

* For **binary** ($X\\in\\{0,1\\}$):
  $$
  \\mathrm{OR}=\\exp(\\beta_1)
  $$
* For **continuous** ($X$): OR must be defined for a specific change in ($X$), commonly **1 SD increase**.

Hypothesis test:
$$
H_0:\\beta_1=0 \\quad \\text{vs}\\quad H_1:\\beta_1\\neq 0
$$

---

### Inputs (what each value means)

1. **Alpha (two-sided)** ($\\alpha$)
   Common choices: 0.05 (standard), 0.01 (more stringent).

2. **Power** ($1-\\beta$)
   Common choices: 0.80 (standard), 0.90 (more conservative).

3. **Baseline event rate** ($p_0$)

   * For **binary predictor**: ($p_0 = P(Y=1\\mid X=0)$) (event rate in the reference group).
   * For **continuous predictor**: ($p_0$) is typically interpreted as the event rate at the **mean** of ($X$) (after centering).

4. **Target odds ratio** ($\\mathrm{OR}$)
   The smallest OR that is clinically meaningful and worth detecting.

5. **Predictor type**

* **Binary predictor**: requires **prevalence of (X=1)**, denoted ($q=P(X=1)$).
* **Continuous predictor**: typically requires the OR for a **1 SD increase** (or you must convert using SD).

6. **($R^2$) with other covariates**
   ($R^2$) is the squared multiple correlation from regressing ($X$) on other covariates in a multivariable model.

   * If ($X$) is correlated with other predictors, the effective information about ($\\beta_1$) decreases, so the required sample size increases.

---

# Calculation

## Step 1 â€” Convert OR and baseline risk to ($p_1$) (binary ($X$))

If ($X$) is binary, compute the event rate in the exposed group ($p_1=P(Y=1\\mid X=1)$) from ($p_0$) and OR:

$$
\\text{odds}_0=\\frac{p_0}{1-p_0},\\quad \\text{odds}_1=\\mathrm{OR}\\cdot \\text{odds}_0,\\quad
p_1=\\frac{\\text{odds}_1}{1+\\text{odds}_1}
$$

Overall event rate:
$$
p=(1-q)p_0+q p_1
$$

## Step 2 â€” Z-scores

Let:
$$
z_{\\alpha}=z_{1-\\alpha/2}, \\qquad z_{\\beta}=z_{1-\\beta}=z_{\\text{power}}
$$

## A) Binary predictor sample size (Hsieh approach)

With ($q=P(X=1)$), ($p_0=P(Y=1\\mid X=0)$), ($p_1=P(Y=1\\mid X=1)$), and ($p$) as above:

$$
n_0=
\\frac{
\\left[
z_{\\alpha}\\sqrt{\\frac{p(1-p)}{q(1-q)}}
+
z_{\\beta}\\sqrt{\\frac{p_1(1-p_1)}{q}+\\frac{p_0(1-p_0)}{1-q}}
\\right]^2
}
{(p_1-p_0)^2}
$$

### Adjustment for correlation with other covariates

If you plan a multivariable model and the predictor of interest ($X$) correlates with other covariates, inflate the sample size using:

$$
n=\\frac{n_0}{1-R^2}
$$

### Expected number of events

$$
E \\approx n\\cdot p
$$

---

## B) Continuous predictor sample size (Hsieh approach)

Assume a logistic model with a continuous predictor ($X$) and define OR for a **1 SD increase** in ($X$), denoted ($\\mathrm{OR}_{SD}$). Let ($p_0$) be the event rate at the mean of ($X$):

$$
n_0=\\frac{(z_{\\alpha}+z_{\\beta})^2}{p_0(1-p_0) [\\log(\\mathrm{OR}_{SD})]^2}
$$

If the user has an OR per 1-unit increase, ($\\mathrm{OR}_{unit}$), and SD of ($X$) is ($\\sigma_X$), convert:
$$
\\log(\\mathrm{OR}_{SD})=\\log(\\mathrm{OR}_{unit})\\cdot \\sigma_X
$$

Then apply the same multivariable correlation inflation:
$$
n=\\frac{n_0}{1-R^2}
$$

---

## Practical guidance: what values to choose (common conventions)

* **($\\alpha$)**: 0.05 (two-sided) is typical; use smaller ($\\alpha$) if multiple testing is expected.
* **Power**: 0.80 is common; 0.90 is preferred when missing the effect would be costly.
* **OR**: choose the **minimum clinically meaningful** OR (often in the 1.2â€“2.0 range depending on context).
* **Baseline risk ($p_0$)**: use local hospital/cohort data if available; otherwise use literature estimates and run sensitivity analyses.
* **Binary predictor prevalence ($q$)**: use local prevalence; note ($q$) near 0.5 gives the **largest information** (smaller ($n$)); very small/large ($q$) increases required ($n$).
* **($R^2$)**: if uncertain, run a sensitivity range (e.g., 0, 0.1, 0.25, 0.5). Even moderate correlation can inflate ($n$) substantially via ($1/(1-R^2)$).
* **Continuous predictors**: consider standardizing ($X$) to mean 0, SD 1 so ($\\mathrm{OR}_{SD}$) is easy to interpret.

---

## Key references (2â€“5)

1. Hsieh FY, Bloch DA, Larsen MD. *A simple method of sample size calculation for linear and logistic regression.* Statistics in Medicine. 1998;17(14):1623â€“1634.
2. Hsieh FY. *Sample size tables for logistic regression.* Statistics in Medicine. 1989;8(7):795â€“802.
3. Whittemore AS. *Sample size for logistic regression with small response probability.* Journal of the American Statistical Association. 1981;76:27â€“32.
""",
    "c5_content_md": """
### What this method is (English - Technical Details)

C5 implements the **Riley et al. analytical minimum sample size criteria** for **developing a multivariable clinical prediction model** with a **binary outcome** (logistic regression). The goal is to ensure the development dataset is large enough to:

1. **Limit overfitting** (via a target global shrinkage / calibration slope),
2. Achieve **adequate precision** for model performance (via a bound on optimism in $R^2$), and
3. Estimate the **overall outcome risk** (intercept/baseline risk) with acceptable precision.

This is a **model development** method (not external validation). It is particularly suitable when you plan a **pre-specified model form** (predictors and coding defined in advance) and want a **principled alternative to EPV rules**.

---

### When to use

Use C5 when:

* You are **developing** a new prediction model for a **binary outcome**.
* You can specify (even approximately) the **event rate** and an anticipated **overall model performance** (Coxâ€“Snell $R^2$ or AUC).
* You want to target **low overfitting** (e.g., shrinkage $S \\ge 0.90$) and reasonable precision.

### When NOT to use (or use with caution)

Do not rely on C5 alone when:

* You will do extensive **data-driven variable selection**, multiple interactions/splines, or heavy ML tuning without adjusting the **effective number of parameters (df)**.
* Your data are strongly **clustered** (multicenter) without accounting for design effects.
* The intended modeling approach is not standard logistic regression (e.g., complex ML) unless you map complexity to an appropriate **effective df** or switch to simulation-based sizing.
* You cannot justify any plausible performance input (AUC/$R^2$); in that case run wide sensitivity analyses and consider simulation-based methods.

---

## Key inputs (what each means)

1. **Outcome prevalence / event rate** (p)
   Expected proportion with (Y=1) in the development dataset.

2. **Number of predictor parameters (df)** (P)
   Total degrees of freedom for all candidate predictors **excluding the intercept**.
   Include: dummy variables, spline bases, interactions (and any other basis expansions).

3. **Anticipated performance** (choose one)

* **Coxâ€“Snell ($R^2_{CS}$)**: preferred if available from related prior studies (ideally optimism-adjusted).
* **AUC (C-statistic)**: if $R^2_{CS}$ is unavailable, the tool can approximate $R^2_{CS}$ from AUC and ($p$) using a published approach.
* **Conservative (15% of max $R^2$)**: a fallback when neither AUC nor $R^2$ is available; use with caution.

4. **Target global shrinkage** (S)
   A target for **overall overfitting control** (often interpreted similarly to an expected calibration slope after internal validation).

* Common default: $S = 0.90$ ($\\approx$ 10% shrinkage of predictor effects).
* More conservative: $S = 0.95$ (requires larger sample size).

---

## Core concepts and formulas

### Coxâ€“Snell ($R^2$) and its maximum

Coxâ€“Snell ($R^2$) for a fitted logistic model can be written as:
$$
R^2_{CS} = 1-\\exp!\\left(\\frac{2}{n}(\\ell_0-\\ell_1)\\right),
$$
where (\\ell_0) is the intercept-only log-likelihood and (\\ell_1) is the model log-likelihood.

For binary outcomes, ($R^2_{CS}$) cannot reach 1. Its maximum depends on the outcome prevalence:
$$
\\ell_0 = n\\Big[p\\ln(p) + (1-p)\\ln(1-p)\\Big],
$$
$$
R^2_{CS,\\max}=1-\\exp!\\left(\\frac{2\\ell_0}{n}\\right)
=1-\\exp!\\Big(2[p\\ln(p) + (1-p)\\ln(1-p)]\\Big).
$$

Nagelkerke ($R^2$) rescales Coxâ€“Snell ($R^2$) to ([0,1]):
$$
R^2_{Nag}=\\frac{R^2_{CS}}{R^2_{CS,\\max}}.
$$

---

## The three Riley criteria (binary outcome)

### Criterion 1 â€” Control overfitting via target shrinkage (S)

Minimum sample size to target global shrinkage (S):
$$
n_1=\\left\\lceil
\\frac{P}{(S-1),\\ln!\\left(1-\\frac{R^2_{CS}}{S}\\right)}
\\right\\rceil.
$$

### Criterion 2 â€” Limit optimism in ($R^2$) (default absolute difference 0.05)

This criterion targets a small absolute difference (default (\\delta=0.05)) between apparent and adjusted **Nagelkerke** ($R^2$). The required shrinkage implied by this constraint is:
$$
S_{\\delta}=\\frac{R^2_{CS}}{R^2_{CS}+\\delta,R^2_{CS,\\max}}.
$$
Then:
$$
n_2=\\left\\lceil
\\frac{P}{(S_{\\delta}-1),\\ln!\\left(1-\\frac{R^2_{CS}}{S_{\\delta}}\\right)}
\\right\\rceil.
$$

### Criterion 3 â€” Precise estimation of the overall outcome risk (intercept)

This targets precision of the **average outcome risk** (p) (baseline risk) within (\\pm d) on the probability scale (default (d=0.05) at 95% CI):
$$
n_3=\\left\\lceil
\\left(\\frac{z_{1-\\alpha/2}}{d}\\right)^2 p(1-p)
\\right\\rceil,
\\quad \\text{default } z_{0.975}=1.96,; d=0.05.
$$

### Final recommendation

$$
n_{\\min}=\\max(n_1,n_2,n_3),\\qquad
E = n_{\\min},p,\\qquad
EPP=\\frac{E}{P}.
$$

---

## Practical guidance (typical choices)

* **Shrinkage (S)**: use **0.90** as a standard target; consider **0.95** if you want stronger overfitting control or if the model is complex.
* **(\\delta=0.05)** for Criterion 2: commonly kept at the default.
* **Intercept precision (d=0.05)**: default corresponds to estimating baseline risk within Â±5%. If baseline risk must be estimated more precisely, you would need a smaller (d) (larger (n)).
* **Anticipated ($R^2_{CS}$)**:

  * Prefer **optimism-adjusted** values from related studies (or apparent values from external validation data).
  * If only AUC is available, use the published AUCâ†’($R^2_{CS}$) approximation method.
  * If neither is available, the **15% of ($R^2_{CS,\\max}$)** option is a conservative fallback for exploratory planningâ€”always run sensitivity analyses.

---

## Key references (2â€“5)

1. Riley RD, Snell KIE, Ensor J, et al. *Minimum sample size required for developing a multivariable prediction model: PART IIâ€”binary and time-to-event outcomes.* Statistics in Medicine. 2019.
2. Riley RD, Ensor J, Snell KIE, et al. *Calculating the sample size required for developing a clinical prediction model.* BMJ. 2020.
3. Riley RD, Van Calster B, Collins GS. *A note on estimating the Coxâ€“Snell ($R^2$) from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a binary outcome.* Statistics in Medicine. 2021.
4. Harrell FE Jr, Lee KL, Mark DB. *Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.* Statistics in Medicine. 1996.
""",
    "c6_content_md": """
## C6: Development Simulation (Frequentist; custom DGM) (English - Technical Details)

### What this method is

C6 is a **simulation-based sample size planning** approach for **prediction model development** (binary outcome), inspired by the philosophy of **samplesizedev** and broader simulation-based design principles.

Instead of relying on a single analytical formula, C6 asks:

> â€œIf we repeatedly develop the model using the planned approach on datasets of size (N), how often will the model meet pre-specified performance criteria on new data?â€

It therefore targets **expected performance** (and/or probability of acceptable performance) under a **data-generating mechanism (DGM)** that represents your anticipated clinical population.

---

## When to use

Use C6 when:

* You want a planning method aligned with â€œ**simulate what you will do**,â€ especially when:

  * predictors may be correlated,
  * you include non-linear terms or interactions,
  * event rates are modest or uncertain,
  * you want criteria based on **calibration** and **discrimination**.
* You can specify a reasonable DGM using local data or the literature.
* You are comfortable with simulation and want a more flexible alternative to purely analytical sizing.

## When NOT to use (or use with caution)

Avoid relying on C6 alone when:

* You cannot justify a plausible DGM (predictor distribution, correlations, effect sizes).
* You do not have computational budget (simulation can be expensive).
* You plan highly data-adaptive ML pipelines (feature selection, complex tuning) without explicitly simulating the full pipeline (C6 must reflect the actual pipeline to be valid).
* The target population is heterogeneous across hospitals/centers and you are not simulating clustering/case-mix shifts.

---

# Overview of the algorithm

For each candidate sample size (N), simulate (R) development datasets, fit the planned model, evaluate it on â€œnew data,â€ and summarize performance.

### Step 1 â€” Choose a DGM

Define how predictors (X) and outcomes (Y) are generated.

Typical binary-outcome DGM:
$$
Y \mid X \sim \\text{Bernoulli}(\\pi), \\qquad
\\pi = \\text{logit}^{-1}(\\eta),
$$
$$
\\eta = \\beta_0 + \\sum_{j=1}^{P}\\beta_j f_j(X_j),
$$
where:

* (P) is the **number of parameters/df** used in the fitted model,
* (f_j(\\cdot)) represent coding choices (linear term, spline basis, dummy coding, etc.).

To achieve a target event rate (p), choose (\\beta_0) so that:
$$
\\mathbb{E}[\\pi] = p.
$$
In practice, (\\beta_0) is found by numerical root-finding using Monte Carlo draws from (X).

### Step 2 â€” Generate a development dataset

For replicate (r):

* Simulate (X^{(r)}) of size (N) from the chosen predictor distribution (with specified correlations).
* Simulate (Y^{(r)}) from the Bernoulli model above.

### Step 3 â€” Fit the development model

Fit the planned logistic regression model:
$$
\\widehat{\\eta} = \\widehat{\\beta}*0 + \\sum*{j=1}^{P}\\widehat{\\beta}_j f_j(X_j).
$$
**Important:** Simulation must match your intended development strategy (e.g., penalization, pre-specified terms). If separation/non-convergence occurs, a ridge-penalized fallback is often used (and should be counted and reported).

### Step 4 â€” Evaluate on new data

Generate an independent test set (size (N_{\\text{test}}), often large such as 5000â€“10000) from the same DGM and compute:

**(a) Discrimination (AUC / C-statistic)**
$$
\\mathrm{AUC}=\\Pr(\\widehat{\\eta}_1 > \\widehat{\\eta}_0),
$$
the probability that a randomly selected case has a higher predicted risk than a non-case.

**(b) Calibration slope**
Estimate (b) from a calibration model on the test set:
$$
\\text{logit}(Y) = a + b \\cdot \\text{logit}(\\widehat{p}),
$$
or equivalently using the linear predictor:
$$
\\text{logit}(Y) = a + b \\cdot \\widehat{\\eta}.
$$
Here, (b\\approx 1) indicates good calibration; (b<1) suggests overfitting (predictions too extreme).

### Step 5 â€” Define pass/fail criteria and compute success rates

Across (R) simulations for each (N), compute:

* Mean calibration slope:
  $$
  \\overline{b} = \\frac{1}{R}\\sum_{r=1}^R b^{(r)}.
  $$
* Probability slope is within an acceptable range:
  $$
  \\widehat{\\Pr}(b \\in [L,U]) = \\frac{1}{R}\\sum_{r=1}^R \\mathbf{1}{b^{(r)}\\in[L,U]}.
  $$
* Mean AUC:
  $$
  \\overline{\\mathrm{AUC}}=\\frac{1}{R}\\sum_{r=1}^R \\mathrm{AUC}^{(r)}.
  $$

A candidate (N) is â€œacceptableâ€ if all selected criteria are met, e.g.:

* (\\overline{b} \\ge 0.90)
* (\\widehat{\\Pr}(0.9 \\le b \\le 1.1) \\ge 0.80)
* (\\overline{\\mathrm{AUC}} \\ge \\mathrm{AUC}_{\\text{target}})

Choose smallest (N) that passes.

---

# Key inputs (where to find, what to pick)

### 1) Event rate (p)

**Where:** local hospital/cohort data; literature default.
**Planning range:** 5%â€“15% (fluctuates by disease).
**Recommendation:** run sensitivity on plausible range.

### 2) Parameters (df) (P)

**Where:** intended model specification (including dummies, splines, interactions).
**Typical:** 10â€“30 df common; more df demands much larger N.

### 3) Target AUC (Mode A)

**Where:** similar published models (ideally external validation); pilot data.
**Typical:** 0.70â€“0.85 common; >0.90 rare/often optimistic.

### 4) Candidates (N)

Choose a range wide enough to see the pass/fail transition (e.g., 1000â€“5000).

### 5) Simulations per N (R)

* Demo: (R \\approx 200)
* Final: (R \\ge 1000)
  Monte Carlo Error for success probability:
  $$
  \\mathrm{MCSE}=\\sqrt{\\frac{\\hat{p}(1-\\hat{p})}{R}}.
  $$

### 6) Pass/Fail Criteria

* Mean calibration slope â‰¥ 0.9
* Pr(0.9 â‰¤ slope â‰¤ 1.1) â‰¥ 80%
* Mean AUC â‰¥ target

**Convention:** slope 0.90-1.10 and 0.80 probability threshold often used for planning; 0.90 for stricter requirements.

---

# Strengths & Weaknesses

**Strengths**

* Flexible (correlation, non-linearity, interactions).
* Targets performance on new data directly, specifically calibration.
* Easy to do sensitivity analysis.

**Weaknesses**

* Strong dependence on DGM assumptions.
* Computationally expensive.
* Must simulate the exact intended pipeline; mismatches lead to invalid N.

---

## Key references (2â€“5)

1. Pavlou M, Ambler G, Seaman SR, et al. *How to develop a more accurate risk prediction model when there are few events.* BMJ. 2015.
2. Riley RD, Snell KIE, Ensor J, et al. *Minimum sample size required for developing a multivariable prediction model: Part IIâ€”binary and time-to-event outcomes.* Statistics in Medicine. 2019.
3. Pavlou M, et al. *Simulation-based sample size calculation for prediction model performance targets* (validation/development methodology). Statistics in Medicine. 2021.
4. Steyerberg EW. *Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating.* 2nd ed. Springer. 2019.
""",
    "c7_content_md": """
## C7: Bayesian Assurance (MCMC) (English - Technical Details)

### What this method is
**Bayesian assurance** is a simulation-based sample size planning method for **Bayesian model building** (here: Bayesian logistic regression for binary outcomes).
Unlike "power" (frequentist), assurance targets the **unconditional probability** that the study will yield a **successful outcome** given the priors.

Simply put:
> "If we repeat the full study many times (generate data + fit Bayes via MCMC), what is the probability the model meets requirements?"

---

### When to use
Use C7 when:
- The final analysis will be **Bayesian** estimated via **MCMC**.
- You want to sample size for a target **success probability** (e.g., â‰¥80% or â‰¥90%).
- You can make reasonable assumptions about:
  - event rates,
  - predictor correlations,
  - plausible effect sizes (pilot/literature),
  - priors for regression coefficients.

### When NOT to use (or use with caution)
- You are doing frequentist analysis (use C5 or C6).
- Computational resources are very limited (MCMC inside simulation is slow).
- You have no idea about priors.
"""
}
